(MedPage Today) — CHICAGO — An investigational biologic against B-cell activating factor (BAFF) appeared effective in treating Sjögren’s disease in twin phase III trials, a researcher reported here, although salivation wasn’t enhanced…
Source link : https://www.medpagetoday.com/meetingcoverage/acr/118237
Author :
Publish date : 2025-10-30 18:36:00
Copyright for syndicated content belongs to the linked Source.
